|
|
Prepublished online as a Blood First Edition Paper on May 8, 2003; DOI 10.1182/blood-2002-11-3337.

Submitted November 6, 2002
Accepted April 28, 2003
Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced intensity conditioning
Juliet N Barker*, Daniel J Weisdorf, Todd E DeFor, Bruce R Blazar, Jeffrey S Miller, and John E Wagner
Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA; Medical Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA
Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA; Pediatric Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA
* Corresponding author; email: barke014{at}umn.edu.
Reduced intensity conditioning may reduce transplant-related mortality in high-risk adults undergoing hematopoietic transplantation. We investigated unrelated donor umbilical cord blood (UCB) transplantation after such conditioning in 43 patients (median age 49.5 years, range 22-65) with a primary end-point of donor engraftment. The first 21 patients received busulfan 8 mg/kg, fludarabine 200 mg/m2, and 200 cGy of total body irradiation (Bu/Flu/TBI). Subsequent patients (n = 22) received cyclophosphamide 50 mg/kg, fludarabine 200 mg/m2, and 200 cGy TBI (Cy/Flu/TBI). UCB grafts (93%) were 1-2 HLA-antigen mismatched with the recipient, and contained a median cryopreserved cell dose of 3.7 x 107 (range: 1.6-6.0) NC/kg. GVHD prophylaxis was cyclosporine-A to day 180 plus mycophenolate mofetil to day 30. The cumulative incidence of sustained donor engraftment was 76% (95%CI: 56-96) for Bu/Flu/TBI recipients and 94% (95%CI: 84-100) for Cy/Flu/TBI recipients. The median day of neutrophil recovery ( 0.5 x 109/l) for engrafting Bu/Flu/TBI recipients was 26 days (range: 12-30) and for Cy/Flu/TBI recipients was 9.5 days (range: 5-28). Incidence of grade III-IV acute GVHD was 9% (95%CI: 1-17), and survival at 1 year was 39% (95%CI: 23-56). These data demonstrate that 0-2 antigen mismatched UCB is sufficient to engraft the majority of adults after reduced intensity conditioning and is associated with a low incidence of severe acute GVHD.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Matsuno, A. Wake, N. Uchida, K. Ishiwata, H. Araoka, S. Takagi, M. Tsuji, H. Yamamoto, D. Kato, Y. Matsuhashi, et al.
Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation
Blood,
August 20, 2009;
114(8):
1689 - 1695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Salinger, D. K. Blough, P. Vicini, C. Anasetti, P. V. O'Donnell, B. M. Sandmaier, and J. S. McCune
A Limited Sampling Schedule to Estimate Individual Pharmacokinetic Parameters of Fludarabine in Hematopoietic Cell Transplant Patients
Clin. Cancer Res.,
August 15, 2009;
15(16):
5280 - 5287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Brunstein, J. E. Wagner, D. J. Weisdorf, S. Cooley, H. Noreen, J. N. Barker, T. DeFor, M. R. Verneris, B. R. Blazar, and J. S. Miller
Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity
Blood,
May 28, 2009;
113(22):
5628 - 5634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. MacMillan, D. J. Weisdorf, C. G. Brunstein, Q. Cao, T. E. DeFor, M. R. Verneris, B. R. Blazar, and J. E. Wagner
Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors
Blood,
March 12, 2009;
113(11):
2410 - 2415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Giassi, T. Pearson, L. D. Shultz, J. Laning, K. Biber, M. Kraus, B. A. Woda, M. R. Schmidt, R. T. Woodland, A. A. Rossini, et al.
Expanded CD34+ Human Umbilical Cord Blood Cells Generate Multiple Lymphohematopoietic Lineages in NOD-scid IL2r{gamma}null Mice
Experimental Biology and Medicine,
August 1, 2008;
233(8):
997 - 1012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. R. Appelbaum
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia When a Matched Related Donor Is Not Available
Hematology,
January 1, 2008;
2008(1):
412 - 417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Brunstein, J. N. Barker, D. J. Weisdorf, T. E. DeFor, J. S. Miller, B. R. Blazar, P. B. McGlave, and J. E. Wagner
Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease
Blood,
October 15, 2007;
110(8):
3064 - 3070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Tallman, G. W. Dewald, S. Gandham, B. R. Logan, A. Keating, H. M. Lazarus, M. R. Litzow, J. Mehta, T. Pedersen, W. S. Perez, et al.
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission
Blood,
July 1, 2007;
110(1):
409 - 417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Antin
Reduced-Intensity Stem Cell Transplantation: "...whereof a little More than a little is by much too much." King Henry IV, part 1, I, 2
Hematology,
January 1, 2007;
2007(1):
47 - 54.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. N. Barker
Umbilical Cord Blood (UCB) Transplantation: An Alternative to the Use of Unrelated Volunteer Donors?
Hematology,
January 1, 2007;
2007(1):
55 - 61.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Section on Hematology/Oncology and Section on Alle
Cord Blood Banking for Potential Future Transplantation
Pediatrics,
January 1, 2007;
119(1):
165 - 170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Brunstein, D. J. Weisdorf, T. DeFor, J. N. Barker, J. Tolar, J.-A. H. van Burik, and J. E. Wagner
Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation
Blood,
October 15, 2006;
108(8):
2874 - 2880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Majhail, D. J. Weisdorf, J. E. Wagner, T. E. Defor, C. G. Brunstein, and L. J. Burns
Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma
Blood,
May 1, 2006;
107(9):
3804 - 3807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Chao
Umbilical Cord Blood: Biology and Transplantation
Am. Assoc. Cancer Res. Educ. Book,
April 1, 2006;
2006(1):
329 - 333.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Ballen
New trends in umbilical cord blood transplantation
Blood,
May 15, 2005;
105(10):
3786 - 3792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Fernandez, C. Regidor, R. Cabrera, G. Bandini, F. Bonifazi, M. Stanzani, M. J. Laughlin, M. Eapen, P. Rubinstein, V. Rocha, et al.
Umbilical-Cord Blood for Transplantation in Adults
N. Engl. J. Med.,
March 3, 2005;
352(9):
935 - 937.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Tse and M. J. Laughlin
Umbilical Cord Blood Transplantation: A New Alternative Option
Hematology,
January 1, 2005;
2005(1):
377 - 383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kami, A. Makimoto, Y. Heike, and Y. Takaue
Reduced-intensity Hematopoietic Stem Cell Transplantation (RIST) for Solid Malignancies
Jpn. J. Clin. Oncol.,
December 1, 2004;
34(12):
707 - 716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kosaka, K. Koh, N. Kinukawa, Y. Wakazono, K. Isoyama, T. Oda, Y. Hayashi, S. Ohta, H. Moritake, M. Oda, et al.
Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation
Blood,
December 1, 2004;
104(12):
3527 - 3534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ichinohe, T. Uchiyama, C. Shimazaki, K. Matsuo, S. Tamaki, M. Hino, A. Watanabe, M. Hamaguchi, S. Adachi, H. Gondo, et al.
Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism
Blood,
December 1, 2004;
104(12):
3821 - 3828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Laughlin, M. Eapen, P. Rubinstein, J. E. Wagner, M.-J. Zhang, R. E. Champlin, C. Stevens, J. N. Barker, R. P. Gale, H. M. Lazarus, et al.
Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia
N. Engl. J. Med.,
November 25, 2004;
351(22):
2265 - 2275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Miyakoshi, K. Yuji, M. Kami, E. Kusumi, Y. Kishi, K. Kobayashi, N. Murashige, T. Hamaki, S.-W. Kim, J.-i. Ueyama, et al.
Successful Engraftment After Reduced-Intensity Umbilical Cord Blood Transplantation for Adult Patients with Advanced Hematological Diseases
Clin. Cancer Res.,
June 1, 2004;
10(11):
3586 - 3592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ooi, T. Iseki, S. Takahashi, A. Tomonari, K. Takasugi, Y. Shimohakamada, T. Yamada, K. Ishii, N. Ohno, F. Nagamura, et al.
Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia
Blood,
January 15, 2004;
103(2):
489 - 491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Chao, S. G. Emerson, and K. I. Weinberg
Stem Cell Transplantation (Cord Blood Transplants)
Hematology,
January 1, 2004;
2004(1):
354 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Kaminski, S. Kadereit, R. E. Miller, P. Leahy, K. R. Stein, D. A. Topa, T. Radivoyevitch, M. L. Veigl, and M. J. Laughlin
Reduced expression of NFAT-associated genes in UCB versus adult CD4+ T lymphocytes during primary stimulation
Blood,
December 15, 2003;
102(13):
4608 - 4617.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|